Science Forum: Improving preclinical studies through replications

  1. Natascha Ingrid Drude
  2. Lorena Martinez Gamboa
  3. Meggie Danziger
  4. Ulrich Dirnagl
  5. Ulf Toelch  Is a corresponding author
  1. Department of Experimental Neurology, Charité–Universitätsmedizin, Germany
  2. BIH QUEST Center for Transforming Biomedical Research, Berlin Institute of Health, Germany
  • Download
  • Cite
  • CommentOpen annotations (there are currently 0 annotations on this page).
1 figure and 1 table

Figures

Increasing different forms of validity (internal, external and translational) during a preclinical research trajectory.

This schematic shows that internal validity (green line) is higher than external validity (orange) and translational validity (blue) at the start of a preclinical research trajectory (left), and …

Tables

Table 1
Overview of three large-scale replication projects in biomedical research: Reproducibility Project: Cancer Biology (RPCB); Brazilian Reproducibility Initiative (BRI); Confirmatory Preclinical Studies (CPS).
RPCBBRICPS
Selection of samples to be replicatedMain findings from 50 high impact citations/publications in cancer researchReplication of 60–100 experiments from research articles of Brazilian studies in different clinical areasTwo-step review process of proposals results in twelve projects
Selection of experimentMain finding from published studiesExperiments using five pre-defined methodsOwn experiments
Replicate own resultsNoNoYes
Exact ProtocolsYes (consulting original authors)NoYes
Blind to initial resultsNoYesNo
Pre-registrationPre-registered study and individual Replication ProtocolsYesYes
Multi-site replicationNoYesYes

Download links